Hiroshi Inami

Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats

Mitsuhiro Kondo, Atsuo Tahara, Kazumi Hayashi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2014 · 49 citations

Inflammation, Cytokine, Anti-inflammatory Action +10

In-vitro Characterization of YM872, a Selective, Potent and Highly Water-soluble α-Amino-3-hydroxy-5-methylisoxazole-4- propionate Receptor Antagonist

Atsuyuki Kohara, Masamichí Okada, Rie Tsutsumi et al. · Journal of Pharmacy and Pharmacology · 1998 · 46 citations · Full text

A regiochemical control in the π-allylpalladium substitution. Preparation of optically active γ-silylallylamines

Hiroshi Inami, Takayori Ito, Hirokazu Urabe et al. · Tetrahedron Letters · 1993 · 35 citations

Engineering, Photochemistry, Regiochemical Control +8

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4 H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

Hiroshi Yamashita, K Ohno, Yoko Amada et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 32 citations

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

K Ohno, Rie Tsutsumi, Naoyuki Matsumoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 25 citations